Literature DB >> 21644833

Overview of the animal health drug development and registration process: an industry perspective.

Robert P Hunter1, Thomas R Shryock, Brian R Cox, Roger M Butler, Jason E Hammelman.   

Abstract

Products for animal health commercialization follow a structured progression from initial concept through to regulatory approval. Typically, products are developed for use in either food animals or companion animals. These can be for the intention of disease intervention, productivity enhancement or improvement in a quality of life capacity. The animal health industry is a regulated industry, meaning that a government agency is responsible for oversight of products, both pre- and post-approval. There are three primary US government agencies that ensure quality, safety and effectiveness for the approval of new products and post-marketing compliance.

Mesh:

Substances:

Year:  2011        PMID: 21644833     DOI: 10.4155/fmc.11.55

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  3 in total

Review 1.  Polypharmacy in Zoological Medicine.

Authors:  Robert P Hunter; Ramiro Isaza
Journal:  Pharmaceutics       Date:  2017-02-22       Impact factor: 6.321

Review 2.  Protecting dogs and cats against the Australian paralysis tick, Ixodes holocyclus (Acari: Ixodidae): A review of the Australian acaricide registration process.

Authors:  Florian Roeber; Maurice Webster
Journal:  Curr Res Parasitol Vector Borne Dis       Date:  2021-10-14

Review 3.  Late-Stage Carbon-14 Labeling and Isotope Exchange: Emerging Opportunities and Future Challenges.

Authors:  Victor Babin; Frédéric Taran; Davide Audisio
Journal:  JACS Au       Date:  2022-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.